Varicella-zoster virus (VZV)-specific cytotoxic T cell responses were studied in 35 presumably immune and two nonimmune adult donors and in two patients with herpes zoster. Peripheral blood lymphocytes (PBLs) were stimulated for five or 12days with autologous, irradiated, VZV-infected PBLs. Cytotoxicity was measured in a chromium-release assay. Target cells were usually cryopreserved, phytohemagglutinin-stimulated PBLs, either infected with VZV or uninfected. In testing the presumably immune adults, VZVspecific cytotoxicity was observed in 32 (91070) of 35 cases after five days and in 19 (90%) of 21 cases after 12 d of stimulation. Lysis of HLA-matched target cells was significantly greater than that of mismatched, VZV-infected target cells after both intervals. Responses were similar when PBLs from two patients with acute zoster were tested after in vitro stimulation and in one of those two tested without in vitro stimulation.
Cell-mediated immunity appears to be important in determining the outcome of varicella-zoster virus (VZV) infections in humans. This conviction is based primarily on observations of the greater frequency and severity of these infections in patients with depressed cellular immunity. One laboratory parameter of cellular immunity in VZV infections is lymphocyte proliferation in response to viral antigens [1, 2] . Another was studied by Gershon and Steinberg [3] , who found that lymphocytes from persons immune to VZV that were stimulated with VZV antigens in vitro were capable of reducing the yield of virus in a plaque-reduction assay,whereas stimulated lymphocytes from nonimmune persons were not. Furthermore, immunocompromised individuals with acute primary or reactivation VZV infections had very low responses that rose during convalescence in survivors. Lymphocytes from immunocompro-mised persons with remote histories of varicella had loweractivity in this assay than did lymphocytes from normal controls positive for antibody to VZV. Levels of serum antibody to VZV were also measured, and no correlation with recovery from infection was found. These results suggest a possible cause-andeffect relationship between an ability to mount this cellular response and recovery from infection. The mechanism by which this effect occurred was not determined. It may have been a direct effect involving cell-to-cell contact, or it may have been mediated by a soluble factor produced by the stimulated lymphocytes. Production of interferon by immune lymphocyctes in response to VZV antigens was reported by Jordan and Merigan [1] .
Certain cellular immune functions in herpesvirus infections involve direct contact between effector cells and virus-infected cells. These effector functions include antibody-dependent, cell-mediated cytotoxicity in herpes simplex virus [4] , cytomegalovirus [5] , and VZV [6] infections and HLA-restricted cytotoxic T cell responses to cytomegalovirus [7] and Epstein-Barr virus [8] . Cytotoxic T cell responses are of particular interest because their occurrence in renal and bone marrow transplant recipients correlates with the ability of patients to recover from cytomegalovirus infections [9, 10] . Lymphocytes from immune donors have recently been reported to kill VZV-infected fibroblasts in a non-HLA-restricted fashion consistent with antibody-dependent, cellmediated cytotoxicity [11] and that lymphocytes from three immune donors, stimulated in vitro, could kill 
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HLA-DR-matched, VZV-infected, Epstein-Barr virus-transformed B cell lines [12] . To define further the nature and significance of VZV-specific cytotoxic T cell responses, we developed a method to stimulate VZV-immune lymphocytes in vitro and measured their ability to lyse VZV-infected target cells.
Subjects and Methods
Study volunteers. Persons tested included 10 healthy adult laboratory workers and 25 randomly selected adult donors who were seen at the Plateletpheresis Center of the National Institutes of Health (Bethesda, Md) or for leukapheresis at the Johns Hopkins Oncology Center (Baltimore, Md). Two additional individuals were tested who were negative for antibody to VZV on duplicate testing and who had no history of chickenpox. Two individuals with active herpes zoster werealso tested serially during their illnesses.
Preparation and passage ofpools ofvirus. The Stevens strain of VZV was used as the infecting virus throughout this study [3] . It was obtained originally in 1975 from a vesicle of a healthy child with chickenpox. It was passaged 20-30 times in whole human embryo fibroblast monolayer cultures (FLOW-5000 cells; Flow Laboratories, Rockville, Md). Pools of cell-associated virus were prepared by treating infected flasks of fibroblasts with trypsin (0.05070), suspending the cells in aliquots of 5-10 x 10 6 cells/mL of RPMI 1640medium with 20070 fetal bovine serum and 10070 dimethyl sulfoxide, freezing them at a rate of 1 C/min in an alcohol-dry ice bath, and transferring them to liquid nitrogen for longterm storage after a temperature of -45 C was reached.
Preparation of VZV-infectedfibroblasts for lymphocyte infection. About 48 h before use for infecting lymphocytes, an aliquot of thawed, VZVinfected fibroblasts was added to monolayer cultures of FLOW-5000 cells at a 1:4 ratio of infected:uninfected cells, a method similar to that used for production of pools of virus. The cells were incubated at 37 C in a humidified atmosphere of 5070 CO 2/95OJo air. Early CPE typical of VZV infection was generally evident by 48 h in >80070 of the cells.
Quantification ofantibody to VZ J( The procedure for the fluorescent antibody to membrane antigen (FAMA) test has been described previously [13, 14] . Glutaraldehyde-fixed, VZV-infected human fibroblasts were incubated for 30 min at 4 C with sera 781 being tested and were washed twice, and fluoresceinconjugated goat antibody to human IgG was added. After another 30-min incubation period and two washes, the cells were suspended in glycerol and examined by fluorescence microscopy. Sera weretested at serial twofold dilutions beginning at 1:2. When FAMA testing was done to quantify antigen expression on infected cells, sera from normal adults positive and negative for antibody to VZV were used.
HLA typing. HLA typing for A and B locus antigens was done using a standard microcytotoxicity assay [15] .
In vitro induction of cytotoxic T cell responses. Effector cells wereprepared by stimulating peripheral blood lymphocytes (PBLs) with autologous VZVinfected lymphocytes and coincubating them for five or 12days at 37 C. The PBLs were obtained by ficollhypaque density gradient centrifugation of either freshly drawn blood or the residual cell pellets from donors having undergone plateletpheresis or leukapheresis within the previous 24 h. PBLs from the latter two sources were usually frozen in aliquots of 1-2 x lOS cells/mL in liquid nitrogen, using methods described above. Before preparation for use in the assay, one or more aliquots of cells were quickly thawed in a water bath at 37 C, slowly diluted with medium containing 20070 fetal bovine serum, washed, and counted.
At the appropriatetime before the assay was done, the fresh or thawed PBLs werewashed, counted, and suspended in medium consisting of RPMI 1640 medium supplemented with 10070 AB-positive serum from a male volunteer, 0.3 mg of L-glutamine/mL, 100 U of penicillin/mL, and 100 J.1g of streptomycin/mL (referred to as medium). Results were similar whether fresh or thawed cells were used. The cells were then counted and divided into two portions. The smaller portion ( rv 25070) was infected with VZV by layering the PBLs onto VZV-infected monolayers of FLOW-5000 cells at a 5:1 ratio of lymphocytes to fibroblasts and incubating them overnight at 37 C in a humidified atmosphere of 5070 CO 2/95OJo air. The fibroblasts had been infected 2 h earlier by addition of infected fibroblasts in a 1:4ratio of infected to uninfected fibroblasts. The following morning the unattached lymphocytes and medium were discarded, new medium was added, and the attached lymphocytes ( rv30OJo-50OJo of the total number) were dispersed into the medium by vigorous tapping of the flasks. The medium containing those cells was removed, more medium was added, and the proce-dure was repeated. 'TYpically, 500/0-750/0 of the attached or adherent lymphocytes harvested in this manner wereFAMA positive for VZV, with 10/0-50/0 of this population consisting of contaminating fibroblasts. The fibroblasts and lymphocytes were readily differentiated by light microscopy. The infection conditions used were selected so that most of the fibroblasts would exhibit early CPEs but would remain attached to the flask. Greater than 90% of the discarded, unattached lymphocytes were FAMA negative. The infected lymphocytes wereused as stimulators after irradiation with UV light for 5 min at a distance of 10 em under two Germicidal Sterilamps'" (Westinghouse, Pittsburgh) yielding 2.5 watts/em? at 10em. In two experiments no infectious VZV was detected in tests of 105 irradiated cells.
Uninfected PBLs were used as responders after they were suspended in medium at a density of 10 6 cells/mL in 25-cm 2 tissue culture flasks (Costar, Cambridge, Mass). The autologous stimulator cells were added to half of the responder cells at a responder-to-stimulator ratio in the range of 3.5:1 to 10:1, and the other half of the responder cells were either sham-stimulated with uninfected UVirradiated lymphocytes or cultured in the absence of stimulator cells. About half of the experiments were done with each type of control, and no responses were noted in either case. Both stimulated and unstimulated responder cells were incubated at 37 C in an atmosphere of 5% CO 2/95 % air for five or 12 days, washed, and counted just before use as effector cells in cytotoxicity assays. For the 12-d coincubations, interleukin-2 (Meloy Laboratories, Springfield, Va)was added at a concentration of ""15 U/mL on day 7. Simultaneously, in some of the assays, additional stimulator cells (autologous VZVinfected, UV-irradiated PBLs) were added, whereas in other assays, stimulator cells were added on day oonly and none were added on day 7.
Measurement of cytotoxicity.
In the initial assays, target cells were prepared from fresh PBLs obtained from healthy adult donors. A portion of cells was infected by cocultivation on VZV-infectedmonolayers of FLOW-5000 cells, and the remainder were left uninfected. For most of the assays,cryopreserved lymphoblast target cells wereused that had been prepared previously from PBLs obtained from adult volunteers undergoing leukapheresis. After separation on ficoll-hypaque gradients, these PBLs were stimulated with phytohemagglutinin (GIBCO Laboratories, Grand Island, NY) for two or three days
Cooper, Vujcic, and Quinnan at a dilution of 1:100-1 :200, previously determined to be the minimal concentration that optimized blast transformation. A portion was then infected by cocultivation on VZV-infectedfibroblasts as described above. After harvesting, aliquots (5-20 X 10 6 cells/ mL) of both infected and uninfected cells were frozen in a programmed biological freezer and stored in liquid nitrogen until needed.
Stimulated and unstimulated lymphocytes prepared for use as effector cells were suspended in medium at the desired concentrations and pipetted in O.1-mL aliquots into wellsof 96-well, U-bottomed microtiter plates (Linbro; Flow Laboratories, MeLean, Va). Target cells were chosen by HLA type so that most of the effectors were tested in quadruplicate against at least two sets of target cells matched at one or more HLA-A and/or HLA-B locus antigens and against one or two sets of mismatched target cells in each assay. For every effector-target combination, the effectors wereprepared in two dilutions so that the effector:target ratios approximated 40:1 and 20:1.
The target cells were used after either overnight infection or revival from liquid nitrogen as described above. On the morning of the assay, the cells were washed, labeled with 100 IlCi of sodium [SlCr]chromate (New England Nuclear, Boston)/mL for 1 h, washed three more times with serum-free medium, and counted. They were suspended at lOS cells/mL, and 0.1 mL was pipetted into each of the appropriate wells of the microtiter plate. The effector cells to be tested were then added at two dilutions to quadruplicate wells. In addition, 0.1 mL of a 200/0-300/0 solution of 23-lauryl ether (Brij@35; Sigma Chemical Co., St. Louis) was added to each of four wells to determine maximal chromium release for each target cell. Spontaneous release of chromium was estimated as the amount released from target cells to which unstimulated lymphocytes had been added. After all the target cells and effector cells were combined in the appropriate wells, the plates were centrifuged at 500 rpm for 3 min to facilitate cell-tocell contact, and then they were incubated for 6 h at 37 C in a humidified atmosphere of 50/0 CO 2/950/0 air. The supernatants were harvested with the Titertek Supernatant Collection System'" (Flow Laboratories, McLean, Va) and were assayed in a gamma counter.
The percent lysis of the infected and uninfected target cells was calculated separately according to the following formula: percent lysis = ([stimulated Some of the PBLs obtained from the two patients with active herpes zoster were tested without prior in vitro stimulation. In these cases, known positive and negative controls, consisting of stimulated and unstimulated cells from an immune donor without active zoster or known recent exposure to VZV, were tested in parallel as effector cells.
The strategy of using frozen cellsas responder cells and target cells was adopted to permit demonstration of the reproducibility of results, as well as to allow for documentation of the suitability of specific target cell preparations. The strategy also made possible evaluation of more volunteers because a single leukapheresis specimen rather than three bleeds per donor could be used to evaluate responsiveness of an individual volunteer.
Results
Titers of antibody to VZl( The two VZV-susceptible donors lacked antibodies by FAMA testing. Of the remaining sera from the 10laboratory workers, titers ranged from 1:16to 1:256.Serum was available from one of the two patients with herpes zoster. The sample obtained on day 7 of the rash had antibodies to VZV at a titer of 1:16. There was no correlation between FAMA titer and results of cytotoxicity assays in the immune donors. Sera were not available for testing from the plateletpheresis donors.
Characterization oftarget cells. In initial experiments using fresh lymphocytes as target cells, VZVspecific cytotoxicity followed a pattern suggestive of HLA restriction involving HLA-A and -B locus antigens. Infected, HLA-matched target cells were lysed at a higher frequency and to a greater extent than were HLA-mismatched or uninfected target cells. However, spontaneous lysis of these target cells was 783 sometimes excessive, and individual target cell preparations could not be tested repeatedly to assess their suitability.
To allow for more rigorous evaluation of HLA restriction and target cell quality by repetitive testing, we developed a bank of cryopreserved, phytohemagglutinin-stimulated lymphocyte target cells. By these methods target cells wereroutinely obtained that had spontaneous chromium release generally about onethird of maximal chromium release, the Brij cpm value ranged from rvl000 to 5000/well, and the variability for each set of replicates was usually <10070. Spontaneous chromium release from infected and uninfected target cells was similar. Five sets of these target cells were evaluated by FAMA testing, and VZV antigens wereseen on 50070-70070 of the infected cells after thawing.
Banked target cell preparations from 21 different donors were prepared. Aliquots of each of these target cells were tested repeatedly in experiments using effector cells from various HLA-matched and -mis- Cytotoxic responses of immune and randomly chosen adult donors. .1Wenty-nine assays were done involving various combinations of the effector cells prepared from the 35 seropositive or randomly chosen adult donors and the 20 sets of infected and uninfected, cryopreserved target cells. Table 2 summarizes the levels of cytotoxicity observed in these experiments. If a given effector-target combination was tested more than once in different assays, the results were averaged, and the mean value was included in table 2, so that each combination is represented only once. At 40:1 effector:target ratios, virusspecific lysis of HLA-matched target cells occurred at significantly higher levels than did lysis of HLAmismatched target cells. This difference was noted when the effector cells were tested after either five or 12 days in culture. At an effector:target ratio of 20:1 after five days of in vitro stimulation, there was a trend in the same direction, and after 12d of in vitro stimulation, lysis of HLA-matched target cells was significantly higher than lysis of HLA-mismatched target cells (P = .007). Autologous target cells were killed at the highest levels.
Mean VZV-specific lysis of matched target cells was greater after 12 d of in vitro stimulation of effectors than after five days, and the reverse was true for lysis of mismatched target cells (table 2) . However, there was no significant difference in the levels of cytotoxicity observed when using effector cells that wererestimulated with autologous VZV-infected lymphocytes on day 7 of the 12-dstimulation period compared with effector cells from the same individuals to which only interleukin-2 was added on day 7 (data not shown). Table 2 reflects the mean results in experiments that were done both ways.
Of the 35 different donors whose cells were tested after five days of in vitro stimulation, 32 (910,10) developed VZV-specific cytotoxic activity against one or more target cells on one or more test dates. Of the three who showed no cytotoxicity, all were tested only once. One of the 32 responding donors was tested against HLA-matched target cells only. For the remaining 31 individuals, the HLA-matched tar- (10) 9 (11) 2 (2)11 3.0 ± 6.4# 2 analysis comparing percent VZV-specific lysis of >20070 and <20070, P values were determined for the difference in lysis between matched and mismatched target cells at each effector-to-target cell ratio. NS = not significant. t The differences in mean percent VZV-specific lysis between HLA-matched and -mismatched target cells at each effector-target cell ratio were tested for statistical significance using the Mann-Whitney rank sum test. t P = .001. § P = .039.
II P = .107. get cells that were killed were lysed to at least twice the extent of any HLA-mismatched target cells in 20 cases (64070).
Of the 21 different donors whose cells were tested after 12 d of in vitro stimulation, 19 (90070) developed VZV-specific cytotoxicity on one or more test dates. Of the two who demonstrated no cytotoxicity, one was tested only once. One of the 19 responding donors was tested against HLA-matched target cellsonly. For the remaining 18individuals, the HLAmatched target cells that were killed were lysed to at least twice the extent of any HLA-mismatched target cells in 15 cases (83070).
The results of eight experiments with effector cells from one randomly chosen donor were examined to further evaluate HLA restriction of the responses. The data from testing responses of this person (HLA type A2, 26; B14, 22) are presented in table 3. The matched target cells had the same antigen as the effector cells at either the A2 or the B14 locus. This person's effector cells caused highly significant lysis of all HLA-matched target cells at both effector:target ratios after either five or 12days of in vitro stimulation. Usually no virus-specific lysis occurred of HLA-mismatched target cells tested in the same assays. The lysis was HLA restricted in these cases to either the A2 or B1410cus because seven of the nonshared antigens present on matched target cells wererepresented on mismatched target cells that were not lysed. Also, both A2 and B14antigens were present on target cells with three different combinations of nonshared antigens, and the HLA-matched target cells were lysed in every case.
Cytotoxic responses of VZ V-susceptible donors. We tested two known VZV-susceptible (FAMA-negative) individuals. One was tested against three sets of matched and one set of mismatched target cells. Lysis of only one target cell, an HLA-matched one, was significant, at a level of 12070 lysis at the 20:1 effector:target ratio. The other susceptible donor was tested against two matched and two mismatched target cells. There was lysis of only one mismatched target cell at levels of 14% and 20070 lysis at the 40:1 and 20:1 effector:target ratios, respectively.
Cytotoxic responses ofdonors with acute herpes zoster. PBLs obtained from two patients with herpes zoster were tested with and without prior in vitro stimulation. Blood was obtained from one individual on days 1, 7, 14, and 21 of the rash. From the other individual, blood was obtained on days 14 and 21. Table 4 gives the results of cytotoxicity testing in these patients. PBLs that were tested without in vitro stimulation were generally devoid of significant VZVspecific cytotoxic activity in our assay, except for cells from donor 2 on day 14 of the rash. These lymphocytes killed all matched target cells but did not kill We demonstrated that lymphocytes from healthy adults, when cocultivated with autologous VZV-infected, UV-irradiated lymphocytes, developed cytotoxicity that was selectivefor VZV-infectedcompared with uninfected target cells and that often appeared restricted by class I histocompatibility antigens. On the basis of two types of results, it also appeared that the effector cell responses involved non-class I antigens in some cases. First, lymphocytes from most donors killed some but not all target cells matched at one or more HLA-A or -B locus antigens. Second, effectors tended to lyse autologous target cells to a greater extent than did allogeneic HLA-matched target cells. In addition, in some cases the effector cells were cytotoxic for target cells with which they shared no HLA-A or -B locus antigens. Restriction by antigens other than class I antigens was reported by Hayward et al. [12] . Although we did not study surface characteristics of the effector cells, it is reasonable to assume that the HLA-restricted responses observed were mediated by cytotoxic T cells [7, 9] .
The capacity of lymphocytes to develop virus-specific HLA-restricted responses in vitro under conditions analogous to those we used is generally dependent on prior immunity of the individual donor [8] . Among immune individuals, varying degrees of responsiveness may be found, such that cells from some persons consistently respond well, some poorly, and some not at all [16, 17] . Because we tested only two VZV-susceptible donors, we cannot be certain that the responses we observed in testing cells from immune donors were dependent on immunologic memory, but we did not see convincing evidence of VZV-specific, HLA-restricted responses when testing cells from the nonimmune donors. We did observe varying degrees of responsivenessamong the immune and presumably immune randomly chosen donors tested. It has been proposed that the degree of responsiveness of memory T cells to influenza virus is related to the number of years since the last infection [16] . The variations in responsiveness we observed could be related to similar factors or to other influences such as immune response genes.
One aspect of the work reported here was the demonstration that phytohemagglutinin-stimulated lymphoblast target cells of various HLA types could be prepared in advance and then frozen in aliquots for later use. This approach allowed for better control of target cell reliability than did using newly prepared target cells in each assay. Target cells could be tested repeatedly for susceptibility to lysis and consistency of performance. Nineteen of 21 sets of target cells prepared consecutively were lysed preferentially by VZV-stimulated effector cells that were matched at one or more HLA-A or -B locus antigens compared 
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with HLA-mismatched effector cells. Cryopreservation of target cells also permitted assays to be done conveniently because target cells of the appropriate HLA types could be chosen and thawed on the same day the assay was done. This advantage was particularly important when testing lymphocytes from individuals with active VZV infections to determine whether HLA-restricted cytotoxic responses developed in vivo.
The specificity of the cytotoxic responses we examined was evaluated using VZV-infected and uninfected target cells. Hayward et al. [12] examined specificity by testing VZV-infected, cytomegalovirus-infected, and herpes simplex virus-infected target cells. Such experiments are informative if the target cells used are known to be susceptible to lysis by effector cells specific for the same viruses with which they are infected. Because neither cytomegalovirus nor herpes simplex virus has been shown to work in systems for induction and measurement of responses analogous to those used here and because experiments to study induction of such responses were outside the scope of this study, we did not do such "specificity" experiments. However, the combined findings of preferential killing of infected compared with uninfected target cells and of HLA restriction justify the interpretation that the effector cells we detected were VZV specific.
The varying susceptibility we observed of different HLA-matched target cells to lysis by effector cells of a given donor could be the result of several factors. First, it could simply be that the assay system was not sensitive enough to detect the responses that occurred in some cases. Concern regarding this possibility was the motivation for developing the cryopreserved target cells that could be tested repeatedly. Because a target cell that was lysed less extensively than the others by effector cells from one donor could be lysed more extensively than the others by effector cells from a different donor, insensitivity of the assay procedure is unlikely to be a complete explanation of the variability in lysis of target cells. Another possible explanation for the variability could have been restriction in some cases by nonclass I histocompatability antigens [18] . Alternatively,in inbred mice, vaccinia virus antigens are recognized in association with some class I antigens in preference to others [19] . In studying variations in killing of influenza virus-infected target cells by effector cells matched to the target cells at HLA-A2, Biddison et al. [20] found that two distinct forms of that antigen existed. The varying susceptibility 787 of VZV-infected target cells to lysis is not surprising, but the explanation requires further study.
The results of our assays done after 12d of cocultivation of stimulators and responders suggested that the cytotoxic responses may be amplified by these culture conditions. The effector cells often lysed HLA-matched target cells to a greater extent after 12 d in culture than after five days, and the reverse was true for mismatched target cells. This method potentially could be extended for cloning cytotoxic T cells and could allow for better definition of their HLA restriction and the reasons for varying susceptibility of target cells to lysis. The results obtained when interleukin-2 was added to cultures of previously stimulated cells differed from those reported when it was added to fresh lymphocyte suspensions. In the latter case, as reported by Ito et al. [21] , natural killer cell activity was enhanced, but there was no HLA-restricted cytotoxicity.
If VZV-specific cytotoxic T lymphocytes develop in the course of acute VZV infections, it is possible that factors affecting this response in vivo in immunosuppressed persons at high risk for complications from herpes zoster or primary varicella may influence the severity of disease. Cytotoxic T lymphocyte responses occur in other herpesvirus infections and are apparently critical for recovery from cytomegalovirus infection [7, 10] . Studies to determine whether long-term memory for cytotoxic T lymphocyte responses could be important in preventing subsequent disease from reinfection or reactivation will also be of interest.
